当前位置:首页 - 行情中心 - 昆药集团(600422) - 财务分析 - 现金流量表

昆药集团

(600422)

  

流通市值:61.77亿  总市值:61.77亿
流通股本:7.57亿   总股本:7.57亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,094,521,859.34860,540,950.227,160,380,415.165,438,368,562.35
  收到的税费返还15,780,600.011,795,801.1213,293,571.825,920,295.84
  收到其他与经营活动有关的现金128,279,787.6927,984,200.79326,873,047.1212,104,505.34
  经营活动现金流入小计2,238,582,247.04890,320,952.137,500,547,034.085,656,393,363.53
  购买商品、接受劳务支付的现金1,551,076,769.77801,950,371.793,744,966,808.882,887,469,504.6
  支付给职工以及为职工支付的现金398,939,356.22242,333,033.06811,455,837.84623,827,170.27
  支付的各项税费199,431,676.37111,277,367.14564,410,153.72501,768,910.02
  支付其他与经营活动有关的现金603,161,821.29348,448,969.862,090,478,130.841,467,164,111.4
  经营活动现金流出小计2,752,609,623.651,504,009,741.857,211,310,931.285,480,229,696.29
  经营活动产生的现金流量净额-514,027,376.61-613,688,789.72289,236,102.8176,163,667.24
二、投资活动产生的现金流量:
  收回投资收到的现金1,644,249,824.8809,087,644.85,309,344,025.762,611,402,378.59
  取得投资收益收到的现金11,081,075.723,559,219.3330,030,603.5531,314,002.63
  处置固定资产、无形资产和其他长期资产收回的现金净额836,697.54395,677.591,781,068.271,129,438.08
  处置子公司及其他营业单位收到的现金净额--4,100,683.22-
  投资活动现金流入小计1,656,167,598.06813,042,541.725,345,256,380.82,643,845,819.3
  购建固定资产、无形资产和其他长期资产支付的现金46,244,714.3632,294,992.0190,559,480.9758,025,860.54
  投资支付的现金1,367,000,000811,000,0005,891,700,0004,060,700,000
  投资活动现金流出小计1,413,244,714.36843,294,992.015,982,259,480.974,118,725,860.54
  投资活动产生的现金流量净额242,922,883.7-30,252,450.29-637,003,100.17-1,474,880,041.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金--16,000,000-
  其中:子公司吸收少数股东投资收到的现金--16,000,000-
  取得借款收到的现金582,692,436.29241,761,560.451,740,208,570.611,392,199,133.63
  筹资活动现金流入小计582,692,436.29241,761,560.451,756,208,570.611,392,199,133.63
  偿还债务支付的现金619,324,808.05322,737,897.8853,059,676.43505,569,385.28
  分配股利、利润或偿付利息支付的现金17,705,902.288,975,445.1280,061,700.27258,056,625.12
  支付其他与筹资活动有关的现金124,178,367.735,896,035.331,277,722,717.79742,386,933.71
  筹资活动现金流出小计761,209,078.06337,609,378.232,410,844,094.491,506,012,944.11
  筹资活动产生的现金流量净额-178,516,641.77-95,847,817.78-654,635,523.88-113,813,810.48
四、汇率变动对现金及现金等价物的影响-2,931,460.87-1,835,325.48-534,546.4711,822.52
五、现金及现金等价物净增加额-452,552,595.55-741,624,383.27-1,002,937,067.65-1,411,818,361.96
  加:期初现金及现金等价物余额1,130,987,344.121,130,987,344.122,133,924,411.772,133,924,411.77
  期末现金及现金等价物余额678,434,748.57389,362,960.851,130,987,344.12722,106,049.81
补充资料:
  净利润-369,694,713.72-419,052,861.68-
  资产减值准备45,417,852.81-31,589,763.74-
  固定资产和投资性房地产折旧52,854,651.91-110,268,016.18-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧52,854,651.91-110,268,016.18-
  无形资产摊销26,275,800.47-56,275,723.24-
  长期待摊费用摊销3,720,792.45-8,232,412.94-
  处置固定资产、无形资产和其他长期资产的损失-1,175,575.72--673,035.91-
  固定资产报废损失123,471.22--499,982.83-
  公允价值变动损失-8,294.49--108,913,808.46-
  财务费用17,307,552.78-50,581,519.23-
  投资损失6,373,078.66--62,011,166.44-
  递延所得税-80,443,049.8-41,962,629.53-
  其中:递延所得税资产减少-78,370,391.05-41,972,468.58-
    递延所得税负债增加-2,072,658.75--9,839.05-
  存货的减少-202,146,810.32-149,981,602.92-
  经营性应收项目的减少270,790,871.38-345,144,197.15-
  经营性应付项目的增加-364,819,949.87--801,271,508.47-
  不涉及现金收支的投资和筹资活动金额其他项目--1,039,406,968.4-
  现金的期末余额678,434,748.57-1,130,987,344.12-
  减:现金的期初余额1,130,987,344.12-2,133,924,411.77-
  现金及现金等价物的净增加额-452,552,595.55--1,002,937,067.65-
公告日期2026-08-222026-04-252026-03-202025-10-25
审计意见(境内)标准无保留意见
TOP↑